Business Daily Media

Men's Weekly

.

Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)

  • Written by PR Newswire

- First approved allogeneic cell therapy product globally for the treatment of CLI

- Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost

- Cipla to market and distribute the drug in India to provide patient access

Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)

MUMBAI, India, Aug. 21, 2020 /PRNewswire/...

More Articles ...

  1. Industry Aficionado Paul Peros Launches World's First Tech-led Full Haircare Precision System-PR Newswire APAC
  2. Party at Home with DJ Tigerlily, Jesabel and Brooklyn on Bigo Live-PR Newswire APAC
  3. Ultima United Limited enters into a binding letter of intent -- Master Lease of Cannington Project-PR Newswire APAC
  4. Higher Logic Australia Has Grown its Customer Base by Over 250% Since the Start of 2020-PR Newswire APAC
  5. US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma-PR Newswire APAC
  6. Streamline End-to-end Records and Ensure Compliance with Newgen's Advanced Records Management System-PR Newswire APAC
  7. Nintex Turns 'Victorian Worker Permit' into a Fully Digital, Mobile Experience-PR Newswire APAC
  8. Nespresso invests in the Democratic Republic of Congo's coffee revival to bring back to life one of the world's most exclusive and finest coffees and improve thousands of lives in Kivu
  9. Sinorbis launches virtual student recruitment fair for China-PR Newswire APAC
  10. Australia Expects to Secure More Hollywood Film Productions to Gold Coast's Village Roadshow Studios on COVID-19 Road to Recovery-PR Newswire APAC

Deputy Announces Exclusive Global Partnership with Predelo to Bring AI to Shift-Based Businesses

Deputy, the global people platform for shift-based businesses, has announced an exclusive partnership with Predelo, an AI Decision Agent-as-a-Serv...

Leftover Budget? The Last-Minute EOFY Tip to Drive Business Success in FY25/26

The countdown is on. With just days left until EOFY, now’s the time to make your remaining 2024–2025 budget work harder and smarter. After workin...

pay.com.au appoints new CEO and Managing Director

The former COO will lead the company’s next growth phase, with ex-CEO Edward Alder transitioning into the role of Managing Director AUSTRALIA, 25...

Tackling the skills shortage — why L&D is failing and what to do about it

The Australian economy is in a tough spot right now, and a huge part of the problem is a massive skills shortage. Late last year, businesses were st...

How reducing revenue leakage could help your business stay in the black in FY2026

It’s time to stop legacy revenue management platforms and processes draining your profitability. Is boosting the bottom line an overarching goal ...

Technical Debt Stifling Path to AI Adoption for Global Enterprises

Outdated legacy technologies costing organisations the ability to innovate, money, time and potentially, even customers Technical debt and an ov...

Sell by LayBy